Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Shenzhen Salubris Pharmaceuticals Co., Ltd.    002294   CNE100000FW8

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

(002294)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
31.28 30.49 31.19 32.23 35.45 Last
5450908 5300018 4378173 7278848 13974650 Volume
+1.99% -2.53% +2.30% +3.33% +9.99% Change
Financials
Sales 2020 3 282 M 506 M 506 M
Net income 2020 571 M 88,1 M 88,1 M
Net cash position 2020 1 706 M 263 M 263 M
P/E ratio 2020 64,9x
Yield 2020 0,77%
Sales 2021 4 034 M 622 M 622 M
Net income 2021 781 M 121 M 121 M
Net cash position 2021 1 854 M 286 M 286 M
P/E ratio 2021 47,4x
Yield 2021 1,08%
Capitalization 36 461 M 5 625 M 5 626 M
EV / Sales 2020 10,6x
EV / Sales 2021 8,58x
Nbr of Employees 4 270
Free-Float 34,6%
More Financials
Company
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company provides two categories of products: pharmaceutical preparation and bulk drugs. The Company distributes its products within domestic market and to overseas markets. 
Sector
Pharmaceuticals
Calendar
01/21 | 07:30amAktionärsversammlung
More about the company
Notations Surperformance© of Shenzhen Salubris Pharmaceuticals Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
2020SHENZHEN SALUBRIS PHARMACEUTICALS CO : annual earnings release
2018SHENZHEN SALUBRIS PHARMACEUTICALS : Announces Investment and In-Licensing Agreem..
BU
More news
News in other languages on SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
2020SHENZHEN SALUBRIS PHARMACEUTICALS CO : publication des résultats annuels
2020SHENZHEN SALUBRIS PHARMACEUTICALS CO : Veröffentlichung des Jahresergebnisses
More news
Chart SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Duration : Period :
Shenzhen Salubris Pharmaceuticals Co., Ltd. Technical Analysis Chart | 002294 | CNE100000FW8 | MarketScreener
Technical analysis trends SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Average target price 22,60 CNY
Last Close Price 35,45 CNY
Spread / Highest target -15,4%
Spread / Average Target -36,2%
Spread / Lowest Target -58,2%
EPS Revisions
Managers and Directors
NameTitle
Sing Ye General Manager & Director
Cheng Hai Ye Chairman
Ai Zhen Li Chairman-Supervisory Board
Jun Liu Chief Financial Officer
Yu Jun Ye Director